CNBX Pharmaceuticals annual operating margin
2016
2017
2018
2019
2020
2022
2023
2024
CNBX Pharmaceuticals Operating Margin Growth & History (CNBX)
CNBX Pharmaceuticals's operating margin was −448.31% for fiscal 2024.
View full CNBX Pharmaceuticals company overviewCNBX Pharmaceuticals annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-08-31 | −448.31% | −221.24 pp |
| 2023 | 2023-08-31 | −227.07% | +9633.30 pp |
| 2022 | 2022-08-31 | −9,860.37% | +32663.75 pp |
| 2020 | 2020-08-31 | −42,524.12% | −8961.11 pp |
| 2019 | 2019-08-31 | −33,563.01% | +6107.11 pp |
| 2018 | 2018-08-31 | −39,670.12% | −7054.02 pp |
| 2017 | 2017-08-31 | −32,616.10% | −32366.61 pp |
| 2016 | 2016-08-31 | −249.49% | — |
CNBX Pharmaceuticals quarterly operating margin
Q2.16
Q3.16
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q3.23
Q4.23
Q1.24
Q2.24
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2024 | 2024-02-29 | −507.98% | +29882.28 pp |
| Q1 2024 | 2023-11-30 | −192.20% | +36420.42 pp |
| Q4 2023 | 2023-08-31 | −161.50% | +65973.46 pp |
| Q3 2023 | 2023-05-31 | −55.80% | +46458.22 pp |
| Q4 2020 | 2020-08-31 | −30,390.26% | +17216.54 pp |
| Q3 2020 | 2020-05-31 | −36,612.62% | −523.64 pp |
| Q2 2020 | 2020-02-29 | −66,134.96% | −27512.25 pp |
| Q1 2020 | 2019-11-30 | −46,514.03% | −26898.59 pp |
| Q4 2019 | 2019-08-31 | −47,606.80% | −23297.80 pp |
| Q3 2019 | 2019-05-31 | −36,088.98% | −7274.47 pp |
| Q2 2019 | 2019-02-28 | −38,622.72% | +49489.45 pp |
| Q1 2019 | 2018-11-30 | −19,615.43% | +10927.86 pp |
| Q4 2018 | 2018-08-31 | −24,309.00% | +13516.86 pp |
| Q3 2018 | 2018-05-31 | −28,814.51% | +1285.81 pp |
| Q2 2018 | 2018-02-28 | −88,112.17% | −72621.82 pp |
| Q1 2018 | 2017-11-30 | −30,543.29% | −30515.60 pp |
| Q4 2017 | 2017-08-31 | −37,825.85% | −36727.50 pp |
| Q3 2017 | 2017-05-31 | −30,100.32% | — |
| Q2 2017 | 2017-02-28 | −15,490.35% | — |
| Q3 2016 | 2016-05-31 | −27.69% | — |
| Q2 2016 | 2016-02-29 | −1,098.35% | — |
CNBX Pharmaceuticals operating margin trends
Over the last five reported fiscal years, CNBX Pharmaceuticals's operating margin increased from −39,670.12% to −448.31%, a change of +39221.80 percentage points. The latest reported quarter, Q2 2024, shows −507.98%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review CNBX Pharmaceuticals filings at SEC.gov ↗